Cite
HARVARD Citation
Takei, T. et al. (2018). Azacitidine effectively reduces TP53-mutant leukemic cell burden in secondary acute myeloid leukemia after cord blood transplantation. Leukemia & lymphoma. 59 (11), pp. 2755-2756. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Takei, T. et al. (2018). Azacitidine effectively reduces TP53-mutant leukemic cell burden in secondary acute myeloid leukemia after cord blood transplantation. Leukemia & lymphoma. 59 (11), pp. 2755-2756. [Online].